Compugen
Biotechnology
Healthcare
CGEN
93.53 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
1.38
52 week high
2.57
high
1.49
52 week low
0.00
previous Close
1.43
P/E ratio
market cap
137 M
div yield
0
net incoming
-7.34 M
-2.24 %
net profit margin
-584.09 %
-269.00 %
operating incoming
-8.43 M
-0.41 %
net change in cash
0.00 %
cash on hand
6.47 M
-55.63 %
cost of revenue
1.67 M
-30.63 %
top